Hariz Hassan, MD, holds a Doctor of Medicine degree from Charles University, obtained between 2006 and 2012. Currently serving as a Consultant Medical Lead at Nykode Therapeutics and Duality Biologics, Hariz Hassan has a robust background in oncology, having worked as a Clinical Oncologist and Investigator at the Institute of Radiation Oncology, Military University Hospital Prague. Additionally, Hariz Hassan has served as the Chief Medical Officer at PRAMOMOLECULAR, along with functioning as a Clinical Development Consultant, demonstrating extensive expertise in medical leadership and clinical development.
This person is not in the org chart